Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing". (May 2018)

• Record Type: Journal Article
• Authors: van Kempen, Zoé LE; Rispens, Theo; Killestein, Joep
• Is Part Of: Multiple sclerosis. Volume 24:Number 6(2018)
• Page Start: 822
• Page End: 823
• Publication Date: 2018-05
• Subjects: Central nervous system -- Diseases -- Periodicals; Myelin sheath -- Diseases -- Periodicals; Inflammation -- Periodicals; Multiple sclerosis -- Periodicals; Central Nervous System Diseases -- Periodicals; Demyelinating Diseases -- Periodicals; Inflammation -- Periodicals; Multiple Sclerosis -- Periodicals; Système nerveux central -- Maladies -- Périodiques; Gaine de myéline -- Maladies -- Périodiques; Inflammation (Pathologie) -- Périodiques; Sclérose en plaques -- Périodiques; Electronic journals; 616.834005
• DOI: 10.1177/1352458517734073
• Languages: English
• ISSNs: 1352-4585